Intelligent pharmaceuticals: beyond the tipping point.
Confluences of key factors can transform apparently isolated or random events into trends. The ongoing and growing pressures facing the pharmaceutical industry have "tipped" the industry toward a new direction in the choice of which new medicines to develop and how to develop them. We examine the factors that are at the tipping point.